Homestead Advisers’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.7M Sell
683,188
-207,600
-23% -$13.6M 1.09% 37
2026
Q1
$63.1M Sell
890,788
-10,100
-1% -$796K 1.69% 28
2025
Q4
$73.9M Sell
900,888
-124,812
-12% -$9.72M 1.96% 22
2025
Q3
$77M Buy
1,025,700
+33,900
+3% +$2.53M 1.83% 23
2025
Q2
$73.5M Buy
991,800
+3,200
+0.3% +$223K 1.74% 24
2025
Q1
$79.8M Buy
988,600
+475,500
+93% +$40.9M 1.95% 20
2024
Q4
$40.1M Buy
513,100
+154,700
+43% +$13.1M 0.97% 45
2024
Q3
$33.6M Buy
+358,400
New +$30.1M 0.8% 46

Other funds holding GEHC

Homestead Advisers's GEHC Position: Q2 2026 in Review

Homestead Advisers reduced its GE HealthCare (GEHC) stake by 23% in Q2 2026, selling an estimated $13.6M and leaving 683,188 shares worth $43.7M. The position accounts for 1.09% of the portfolio, ranked #37.

Homestead Advisers first reported a position in GEHC in Q3 2024 and has held it in 8 quarters since. The position peaked at $79.8M in Q1 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Homestead Advisers held 683,188 shares of GE HealthCare worth $43.7M as of Q2 2026.
  • Homestead Advisers sold 207,600 GE HealthCare shares in Q2 2026, an estimated $13.6M.
  • GE HealthCare made up 1.09% of Homestead Advisers's portfolio in Q2 2026, its #37 holding.
  • Homestead Advisers first reported a position in GE HealthCare in Q3 2024 and has held it in 8 quarters since.
  • Homestead Advisers's GE HealthCare position peaked at $79.8M in Q1 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Homestead Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.